Esterified estrogens
Sodium equilin sulfate Estrogen | | |
Clinical data | ||
---|---|---|
Trade names | Estratab, Menest, others | |
Other names | Esterified oestrogens; EEs; Esterified equine estrogens; Esterified equine oestrogens; EEEs | |
Routes of administration | By mouth[1] | |
Drug class | Estrogen | |
ATC code |
| |
Legal status | ||
Legal status | ||
Identifiers | ||
PubChem SID | ||
DrugBank | ||
UNII |
Esterified estrogens (EEs), sold under the brand names Estratab and Menest among others, is an
EEs were introduced for medical use by 1970.[9] They are available in only a few countries, such as Chile and the United States.[3] They have also been marketed in Argentina and Switzerland in the past.[3]
Medical uses
EEs are used in
Route/form | Estrogen | Low | Standard | High | |||
---|---|---|---|---|---|---|---|
Oral | Estradiol | 0.5–1 mg/day | 1–2 mg/day | 2–4 mg/day | |||
Estradiol valerate | 0.5–1 mg/day | 1–2 mg/day | 2–4 mg/day | ||||
Estradiol acetate | 0.45–0.9 mg/day | 0.9–1.8 mg/day | 1.8–3.6 mg/day | ||||
Conjugated estrogens | 0.3–0.45 mg/day | 0.625 mg/day | 0.9–1.25 mg/day | ||||
Esterified estrogens | 0.3–0.45 mg/day | 0.625 mg/day | 0.9–1.25 mg/day | ||||
Estropipate | 0.75 mg/day | 1.5 mg/day | 3 mg/day | ||||
Estriol | 1–2 mg/day | 2–4 mg/day | 4–8 mg/day | ||||
Ethinylestradiola | 2.5–10 μg/day | 5–20 μg/day | – | ||||
Nasal spray | Estradiol | 150 μg/day | 300 μg/day | 600 μg/day | |||
Transdermal patch | Estradiol | 25 μg/dayb | 50 μg/dayb | 100 μg/dayb | |||
Transdermal gel |
Estradiol | 0.5 mg/day | 1–1.5 mg/day | 2–3 mg/day | |||
Vaginal |
Estradiol | 25 μg/day | – | – | |||
Estriol | 30 μg/day | 0.5 mg 2x/week | 0.5 mg/day | ||||
SC injection |
Estradiol valerate | – | – | 4 mg 1x/4 weeks | |||
Estradiol cypionate | 1 mg 1x/3–4 weeks | 3 mg 1x/3–4 weeks | 5 mg 1x/3–4 weeks | ||||
Estradiol benzoate | 0.5 mg 1x/week | 1 mg 1x/week | 1.5 mg 1x/week | ||||
SC implant | Estradiol | 25 mg 1x/6 months | 50 mg 1x/6 months | 100 mg 1x/6 months | |||
Footnotes: a = No longer used or recommended, due to health concerns. b = As a single patch applied once or twice per week (worn for 3–4 days or 7 days), depending on the formulation. Note: Dosages are not necessarily equivalent. Sources: See template. |
Available forms
EEs are available in the form of 0.3 mg, 0.625 mg, 1.25 mg, and 2.5 mg
Side effects
Pharmacology
EEs consist primarily of
Estrogen | HF |
VE | UCa | FSH | LH | HDL -C | SHBG | CBG |
AGT |
Liver |
---|---|---|---|---|---|---|---|---|---|---|
Estradiol | 1.0 | 1.0 | 1.0 | 1.0 | 1.0 | 1.0 | 1.0 | 1.0 | 1.0 | 1.0 |
Estrone | ? | ? | ? | 0.3 | 0.3 | ? | ? | ? | ? | ? |
Estriol | 0.3 | 0.3 | 0.1 | 0.3 | 0.3 | 0.2 | ? | ? | ? | 0.67 |
Estrone sulfate | ? | 0.9 | 0.9 | 0.8–0.9 | 0.9 | 0.5 | 0.9 | 0.5–0.7 | 1.4–1.5 | 0.56–1.7 |
Conjugated estrogens | 1.2 | 1.5 | 2.0 | 1.1–1.3 | 1.0 | 1.5 | 3.0–3.2 | 1.3–1.5 | 5.0 | 1.3–4.5 |
Equilin sulfate |
? | ? | 1.0 | ? | ? | 6.0 | 7.5 | 6.0 | 7.5 | ? |
Ethinylestradiol | 120 | 150 | 400 | 60–150 | 100 | 400 | 500–600 | 500–600 | 350 | 2.9–5.0 |
Diethylstilbestrol | ? | ? | ? | 2.9–3.4 | ? | ? | 26–28 | 25–37 | 20 | 5.7–7.5 |
Sources and footnotes
Notes: Values are ratios, with estradiol as standard (i.e., 1.0). Abbreviations: HF = Clinical relief of liver proteins. Liver = Ratio of liver estrogenic effects to general/systemic estrogenic effects (hot flashes/gonadotropins ). Sources: See template. |
Compound | RBA to (%)SHBG |
Bound to SHBG (%) |
Bound to albumin (%) |
Total bound (%) |
MCR (L/day/m2) |
---|---|---|---|---|---|
17β-Estradiol | 50 | 37 | 61 | 98 | 580 |
Estrone | 12 | 16 | 80 | 96 | 1050 |
Estriol | 0.3 | 1 | 91 | 92 | 1110 |
Estrone sulfate | 0 | 0 | 99 | 99 | 80 |
17β-Dihydroequilin | 30 | ? | ? | ? | 1250 |
Equilin | 8 | 26 | 13 | ? | 2640 |
17β-Dihydroequilin sulfate |
0 | ? | ? | ? | 375 |
Equilin sulfate |
0 | ? | ? | ? | 175 |
Δ8-Estrone | ? | ? | ? | ? | 1710 |
Notes: RBA for SHBG (%) is compared to 100% for testosterone. Sources: See template. |
Chemistry
EEs contain
History
EEs were introduced for medical use by 1970.[9]
Society and culture
Generic names
Estrogens, esterified is the
Brand names
EEs are marketed under a variety of brand names including Amnestrogen, Estragyn, Estratab, Evex, Femibel, Femogen, Menest, Neo Estrone Tab, and Oestro-Feminal alone, and, in combination with methyltestosterone, under the brand names Covaryx, Delitan, Eemt, Essian, Estratest, Feminova-T, Menogen, and Syntest.[3][6][4]
Availability
EEs are or have been marketed in Argentina, Chile, Switzerland, and the United States.[3] Both EEs and the combination of EEs and methyltestosterone are listed as being marketed only in Chile and the United States as of present.[3]
See also
- Esterified estrogens/methyltestosterone
- Estrogenic substances
- Conjugated estriol
- List of combined sex-hormonal preparations
References
- ^ ISBN 978-1-4614-6268-2.
- FDA. Retrieved 22 Oct 2023.
- ^ ISBN 978-0-85369-840-1.
- ^ a b c d e f "Esterified estrogens".
- ^ S2CID 24616324.
- ^ ISBN 978-0-312-67646-9.
- ^ S2CID 23850792.
- ISBN 978-3-642-67570-6.
- ^ a b Northwest Medicine. Vol. 69. Northwest Medical Pub. Association. 1970.
- ^ ISBN 978-1-4200-4744-8.
- ^ "Drugs@FDA: FDA Approved Drug Products". United States Food and Drug Administration. Retrieved 30 March 2018.
- ISBN 978-1-59259-715-4.
- ^ ISBN 978-1-4511-4847-3.
- ISBN 978-1-59486-927-3.
- ^ PMID 15467060.
- PMID 16505258.
- ^ "Estrogens, Esterified (USP) - Searchable synonyms, formulas, resource links, and other chemical information". ChemIDplus. U.S. Library of Medicine. D042724000.